Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1831001
Max Phase: Preclinical
Molecular Formula: C21H31ClN4
Molecular Weight: 338.50
Molecule Type: Small molecule
Associated Items:
ID: ALA1831001
Max Phase: Preclinical
Molecular Formula: C21H31ClN4
Molecular Weight: 338.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)Cn1c2ccccc2c2ccnc(CNCCCN(C)C)c21.Cl
Standard InChI: InChI=1S/C21H30N4.ClH/c1-16(2)15-25-20-9-6-5-8-17(20)18-10-12-23-19(21(18)25)14-22-11-7-13-24(3)4;/h5-6,8-10,12,16,22H,7,11,13-15H2,1-4H3;1H
Standard InChI Key: BWTVBKQYUAXADY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 338.50 | Molecular Weight (Monoisotopic): 338.2470 | AlogP: 3.89 | #Rotatable Bonds: 8 |
Polar Surface Area: 33.09 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.48 | CX LogP: 3.06 | CX LogD: 0.90 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.63 | Np Likeness Score: -0.79 |
1. Chen Z, Cao R, Shi B, Guo L, Sun J, Ma Q, Fan W, Song H.. (2011) Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents., 46 (10): [PMID:21875764] [10.1016/j.ejmech.2011.08.027] |
Source(1):